SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001420506-24-000003
Filing Date
2024-01-03
Accepted
2024-01-03 16:56:57
Documents
1
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_1100.html 4  
1 PRIMARY DOCUMENT doc4_1100.xml 4 3244
  Complete submission text file 0001420506-24-000003.txt   4802
Mailing Address C/O ONCORE BIOPHARMA, INC. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address
Ramaswamy Vivek (Reporting) CIK: 0001635075 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 24507773

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)